A phase III randomized , placebo-controlled , double-blind clinical trial at @ North American sites consisting of participants @ years of age or older who received a diagnosis of PD within @ years and who had the following inclusion criteria : the presence of a rest tremor , bradykinesia , and rigidity ; a modified Hoehn and Yahr stage of @ or less ; and no anticipated need for dopaminergic therapy within @ months .